Singular Genomics to Present at Cowen’s 43rd Annual Health Care Conference

Rhea-AI Summary

Singular Genomics Systems (Nasdaq: OMIC) has announced its participation at Cowen’s 43rd Annual Health Care Conference in Boston on March 7, 2023. The company's management will engage in a fireside chat at 8:10 a.m. PT / 11:10 a.m. ET. Interested investors can access a live and recorded webcast of this presentation through their investor relations website.

Singular Genomics is advancing life science technology with its G4 Sequencing Platform and developing the PX system, aiming to enhance research and clinical outcomes through next-generation sequencing and multiomics technologies.

SAN DIEGO, Feb. 23, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced plans to present at Cowen’s 43rd Annual Health Care Conference in Boston, Massachusetts.

Singular Genomics’ management is scheduled to participate in a fireside chat Tuesday, March 7, 2023, at 8:10 a.m. Pacific Time / 11:10 a.m. Eastern Time. Investors and other interested parties are invited to listen to a live and recorded webcast of the presentation at investor.singulargenomics.com, in the News & Events section.

About Singular Genomics Systems, Inc.

Singular Genomics is a life science technology company that develops next-generation sequencing and multiomics technologies. The commercially available G4 Sequencing Platform is a powerful, highly versatile benchtop genomic sequencer designed to produce fast and accurate results. In development, the PX system leverages Singular’s proprietary sequencing technology, applying it as an in-situ readout to look at RNA and proteins in single cells and tissue. With these products, Singular Genomics’ mission is to empower researchers and clinicians to advance science and medicine. Visit www.singulargenomics.com for more information.

Investor Contact

Matt Clawson
949-370-8500
ir@singulargenomics.com

Media Contact

Dan Budwick, 1AB
973-271-6085
dan@1abmedia.com

FAQ

When will Singular Genomics present at the Cowen Annual Health Care Conference?

Singular Genomics will present on March 7, 2023, at 8:10 a.m. PT / 11:10 a.m. ET.

How can I listen to Singular Genomics' presentation?

The presentation can be accessed via a live and recorded webcast on their investor relations website.

What technologies does Singular Genomics focus on?

Singular Genomics specializes in next-generation sequencing and multiomics technologies.

What is the G4 Sequencing Platform?

The G4 Sequencing Platform is a versatile benchtop genomic sequencer developed by Singular Genomics.

What is the purpose of the PX system being developed by Singular Genomics?

The PX system aims to perform in-situ readouts to analyze RNA and proteins in single cells and tissue.